What Bioxydyn say about themselves
“Bioxydyn provides quantitative MRI biomarker services for pharma and clinical trials. Global CRO since 2009.”
“Bioxydyn provides quantitative MRI biomarker services for pharma and clinical trials. Global CRO since 2009.”
Officer details are public data from the Companies House register.
People and entities with significant control, from the Companies House PSC register
Figures from 2024 accounts. Newer accounts, made up to 30 November 2025, are filed but not read yet. See them on Companies House
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £1,002,821 | £1,004,475 | £1,013,873 | £1,010,723 | £2,770,769 | £2,776,167 |
| Current Assets | £234,168 | £257,812 | £107,790 | £216,185 | £382,207 | £92,805 |
| Debtors | £212,202 | £209,845 | £100,489 | £30,568 | £246,030 | £70,766 |
| Cash | £21,966 | £47,967 | £7,301 | £185,617 | £136,177 | £22,039 |
| Creditors (< 1 year) | £309,385 | £354,929 | £306,428 | £289,458 | £99,299 | |
| Creditors (> 1 year) | £203,297 | £200,151 | £221,574 | £332,978 | £674,145 | |
| Net Current Assets | (£75,217) | (£97,117) | (£198,638) | (£73,273) | £282,908 | (£434,908) |
| Net Assets | £724,307 | £707,207 | £593,661 | £604,472 | £2,379,532 | £2,341,259 |
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 11 September 2026 | Confirmation statement with no updates | 7 September 2026 | ||
| 31 August 2026 | Total exemption full accounts | 30 November 2025 | ||
| 30 November 2025 | Total exemption full accounts | 30 November 2024 | ||
| 23 October 2025 | Confirmation statement with no updates | 7 September 2025 | ||
| 22 October 2025 | Secretary's details changed |
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →